# China NMPA Drug Inspection - Gansu Xuanyuan Pharmaceutical Development Co., Ltd. - Honey Mulberry Bark

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/gansu-xuanyuan-pharmaceutical-development-co-ltd/ba95f7b9-c6ab-4443-9795-12fed4515918
Source feed: China

> China NMPA drug inspection for Gansu Xuanyuan Pharmaceutical Development Co., Ltd. published March 20, 2020. Drug: Honey Mulberry Bark. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Gansu Provincial Drug Administration Regarding Sampling Inspection Information of Drugs Used for COVID-19 Prevention and Control
- Company Name: Gansu Xuanyuan Pharmaceutical Development Co., Ltd.
- Publication Date: 2020-03-20
- Drug Name: Honey Mulberry Bark
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/gansu-xuanyuan-pharmaceutical-development-co-ltd/8f09032d-e727-4d33-b3ab-5b0e044a97f0